These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
204 related items for PubMed ID: 9648959
1. Bronchodilator response to salbutamol after chronic dosing with salmeterol or placebo. Langley SJ, Masterson CM, Batty EP, Woodcock A. Eur Respir J; 1998 May; 11(5):1081-5. PubMed ID: 9648959 [Abstract] [Full Text] [Related]
6. Tolerance to the protective effects of salmeterol on methacholine-induced bronchoconstriction: influence of inhaled corticosteroids. Boulet LP, Cartier A, Milot J, Côté J, Malo JL, Laviolette M. Eur Respir J; 1998 May 11; 11(5):1091-7. PubMed ID: 9648961 [Abstract] [Full Text] [Related]
7. Bronchodilator subsensitivity to salbutamol after twice daily salmeterol in asthmatic patients. Grove A, Lipworth BJ. Lancet; 1995 Jul 22; 346(8969):201-6. PubMed ID: 7616798 [Abstract] [Full Text] [Related]
8. Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness. Rosenthal RR, Busse WW, Kemp JP, Baker JW, Kalberg C, Emmett A, Rickard KA. Chest; 1999 Sep 22; 116(3):595-602. PubMed ID: 10492259 [Abstract] [Full Text] [Related]
9. Salmeterol reduces the need for inhaled corticosteroid in steroid-dependent asthmatics. Nielsen LP, Pedersen B, Faurschou P, Madsen F, Wilcke JT, Dahl R. Respir Med; 1999 Dec 22; 93(12):863-8. PubMed ID: 10653047 [Abstract] [Full Text] [Related]
10. Comparison of salmeterol with beclomethasone in adult patients with mild persistent asthma who are already on low-dose inhaled steroids. Vermetten FA, Boermans AJ, Luiten WD, Mulder PG, Vermue NA. J Asthma; 1999 Dec 22; 36(1):97-106. PubMed ID: 10077139 [Abstract] [Full Text] [Related]
11. Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol. Kalra S, Swystun VA, Bhagat R, Cockcroft DW. Chest; 1996 Apr 22; 109(4):953-6. PubMed ID: 8635376 [Abstract] [Full Text] [Related]
12. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma. Pearlman DS, Stricker W, Weinstein S, Gross G, Chervinsky P, Woodring A, Prillaman B, Shah T. Ann Allergy Asthma Immunol; 1999 Mar 22; 82(3):257-65. PubMed ID: 10094216 [Abstract] [Full Text] [Related]
13. A twelve-week comparison of salmeterol and salbutamol in the treatment of mild-to-moderate asthma: a Canadian multicenter study. Boulet LP, Laviolette M, Boucher S, Knight A, Hébert J, Chapman KR. J Allergy Clin Immunol; 1997 Jan 22; 99(1 Pt 1):13-21. PubMed ID: 9003206 [Abstract] [Full Text] [Related]
14. A 1-week dose-ranging study of inhaled salmeterol in patients with asthma. Bronsky EA, Kemp JP, Orgel HA, Bierman CW, Tinkelman DG, van As A, Liddle RF. Chest; 1994 Apr 22; 105(4):1032-7. PubMed ID: 7909285 [Abstract] [Full Text] [Related]
20. Long-acting beta2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial. Lazarus SC, Boushey HA, Fahy JV, Chinchilli VM, Lemanske RF, Sorkness CA, Kraft M, Fish JE, Peters SP, Craig T, Drazen JM, Ford JG, Israel E, Martin RJ, Mauger EA, Nachman SA, Spahn JD, Szefler SJ, Asthma Clinical Research Network for the National Heart, Lung, and Blood Institute. JAMA; 2007 Jul 22; 285(20):2583-93. PubMed ID: 11368732 [Abstract] [Full Text] [Related] Page: [Next] [New Search]